Warning Letter Roundup: FDA Flags Labeling, Sterility, Other Violations By Sam | December 11, 2017 The FDA warned four companies for illegally branding cannabidiol products as treatments for cancer and Alzheimer’s disease. Source: Drug GMP Report Posted in Drug GMP Report